相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Extended real-world experience with the ILUVIEN (R) (fluocinolone acetonide) implant in the United Kingdom: 3-year results from the Medisoft (R) audit study
Clare Bailey et al.
EYE (2022)
Two-year interim safety results of the 0.2 μg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study
Sam E. Mansour et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2021)
Effectiveness and tolerability of the fluocinolone acetonide implant in patients with diabetic macular edema in UAE: 12-Month results
Ahmed Mohammed Elbarky
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2021)
Real-World Efficacy and Safety of Fluocinolone Acetonide Implant for Diabetic Macular Edema: A Systematic Review
Laurent Kodjikian et al.
PHARMACEUTICS (2021)
The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema (Jan, 10.1038/s41433-020-01373-1, 2021)
Maria Vittoria Cicinelli et al.
EYE (2021)
Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN® (0.19 mg fluocinolone acetonide implant)
Albert J. Augustin et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2020)
Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data
Srinivas R. Sadda et al.
EYE (2020)
Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment
Matus Rehak et al.
ACTA DIABETOLOGICA (2020)
The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema
Sara Vaz-Pereira et al.
OPHTHALMIC RESEARCH (2020)
Retinal thickness fluctuations in patients receiving fluocinolone acetonide implant for diabetic macular edema
Sarah E. Holden et al.
CURRENT MEDICAL RESEARCH AND OPINION (2020)
Reduction in Retinal Thickness Fluctuations After Treatment With Fluocinolone Acetonide Implant for DME: A Post-Hoc Analysis of the USER Study
Christopher D. Riemann et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2020)
Fluocinolone acetonide (0.19 mg) intravitreal implant reduces treatment burden and improves practice resource utilisation for patients with diabetic macular oedema
Matthew Byun et al.
BMJ OPEN OPHTHALMOLOGY (2020)
Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries
Usha Chakravarthy et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
First-line treatment algorithm and guidelines in center-involving diabetic macular edema
Laurent Kodjikian et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2019)
The USER Study: A Chart Review of Patients Receiving a 0.2μg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema
Alexander Eaton et al.
OPHTHALMOLOGY AND THERAPY (2019)
Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema
Sidney A. Schechet et al.
BMJ OPEN OPHTHALMOLOGY (2019)
Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edema
Joseph M. Coney
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL (2019)
Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME)
Jessica D. McCluskey et al.
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL (2019)
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment A Secondary Analysis of a Randomized Clinical Trial
Neil M. Bressler et al.
JAMA OPHTHALMOLOGY (2018)
Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies
Claudio Bucolo et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)
Real-world Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States
Thomas A. Ciulla et al.
OPHTHALMOLOGY RETINA (2018)
The Pattern of Recurrence in Diabetic Macular Edema Treated by Dexamethasone Implant: The PREDIAMEX Study
David Bellocq et al.
OPHTHALMOLOGY RETINA (2018)
Pharmacology of Corticosteroids for Diabetic Macular Edema
Scott M. Whitcup et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)
Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom
C. Bailey et al.
EYE (2017)
Diabetic Retinopathy: A Position Statement by the American Diabetes Association
Sharon D. Solomon et al.
DIABETES CARE (2017)
Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials
Ronald P. Danis et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2016)
Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy
Rehan M. Hussain et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
Characterization of Intraocular Pressure Increases and Management Strategies Following Treatment With Fluocinolone Acetonide Intravitreal Implants in the FAME Trials
Richard K. Parrish et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2016)
REAL-LIFE STUDY IN DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT
Ariane Malclès et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)
Ocular Pharmacokinetics of Fluocinolone Acetonide Following Iluvien Implantation in the Vitreous Humor of Rabbits
Frances E. Kane et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2015)
INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA Pharmacokinetic Considerations
Yit Yang et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Ryan Lee et al.
EYE AND VISION (2015)
Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
David S. Boyer et al.
OPHTHALMOLOGY (2014)
Diabetic macular edema: new concepts in patho-physiology and treatment
Xinyuan Zhang et al.
CELL AND BIOSCIENCE (2014)
Aqueous Levels of Fluocinolone Acetonide after Administration of Fluocinolone Acetonide Inserts or Fluocinolone Acetonide Implants
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2013)
Dexamethasone Intravitreal Implant in Combination with Laser Photocoagulation for the Treatment of Diffuse Diabetic Macular Edema
David G. Callanan et al.
OPHTHALMOLOGY (2013)
Fluocinolone acetonide and its potential in the treatment of chronic diabetic macular edema
Christos Haritoglou et al.
CLINICAL OPHTHALMOLOGY (2013)
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Joanne W. Y. Yau et al.
DIABETES CARE (2012)
Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2012)
Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2011)
Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant
Joan-En Chang-Lin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Differentiating Intraocular Glucocorticoids
Jeffrey L. Edelman
OPHTHALMOLOGICA (2010)
Sustained Ocular Delivery of Fluocinolone Acetonide by an Intravitreal Insert
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2010)
CORRELATION OF VISUAL ACUITY AND MACULAR THICKNESS MEASURED BY OPTICAL COHERENCE TOMOGRAPHY IN PATIENTS WITH PERSISTENT MACULAR EDEMA
Mark S. Blumenkranz et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
A central role for inflammation in the pathogenesis of diabetic retinopathy
AM Joussen et al.
FASEB JOURNAL (2004)
分享论文
